sur Relief Therapeutics Holding SA (ETR:RLF)
MindMaze and Vibra Healthcare Unveil Promising Neurorehabilitation Results
MindMaze Therapeutics and Vibra Healthcare have disclosed promising results from a two-year program that showcases the benefits of high-dose, high-intensity therapy for stroke patients. Conducted across five Vibra inpatient facilities, the study involved 210 participants and highlighted significant improvements in functional recovery. This was achieved through supplemental, gamified therapy, addressing gaps in traditional care hampered by staffing and patient fatigue.
The study revealed that patients utilizing MindMaze's technology experienced notable gains in mobility and self-care. Therapy intensity increased by 60%, with patients engaging in training on 75% of enrolled days. Enhanced community discharge rates were also observed, facilitating quicker returns to home environments.
The technology employed, including MindMotion Go, was designed to deliver whole-body training, ensuring minimized therapist involvement while maintaining patient engagement. Feedback indicated a positive patient experience, with 77% acknowledging mobility improvements. Leaders from both organizations emphasized the scalable potential of the approach, aiming to redefine neurorehabilitation standards.
R. E.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Relief Therapeutics Holding SA